Two major trials unveiled at the 2026 Society of Gynecologic Oncology meeting are reshaping ovarian cancer treatment. NRG-GY019 confirmed carboplatin-paclitaxel followed by letrozole as the standard ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results